Innovation in Warts and Molluscum: An Updated Comprehensive Review.

Stephen K Tyring, Kritin K Verma, Kevin M Burningham

Journal: Dermatologic clinics 2024;43(1):95-102

PMID: 39542567

Full Text on Elsevier Science View on PubMed

Abstract

This comprehensive review article gives an up-to-date assessment of the therapeutic landscape for warts and molluscum contagiosum (MC), focusing on advances made in the last 5 years. New treatment choices include VP-102 (Ycanth) for molluscum contagiosum, potentially intralesional Vitamin D3 for warts, and topical cidofovir for both. Immunotherapy is regarded as a potential option, especially in difficult situations. Traditional therapies like cryotherapy and keratolytic medicines remain the principal options. The study emphasizes the need for personalized treatment strategies and additional research to improve therapy efficacy and safety.

Address: School of Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, USA. Electronic address: [email protected].; Department of Clinical Research, Center for Clinical Studies, LTD, Webster, TX 77598, USA.; Department of Clinical Research, Center for Clinical Studies, LTD, Webster, TX 77598, USA; Department of Dermatology, The University of Texas Health Science Center at Houston, Bellaire, TX 77401, USA.

DOI: 10.1016/j.det.2024.08.007

Link outs

Free resources

Medical:

https://medlineplus.gov/warts.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Antiviral Agents, Cidofovir, Cryotherapy, Immunotherapy, Keratolytic Agents, Molluscum Contagiosum, Warts